311 related articles for article (PubMed ID: 12414630)
1. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Ramos-Nino ME; Timblin CR; Mossman BT
Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
[TBL] [Abstract][Full Text] [Related]
2. Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers.
Timblin CR; Guthrie GD; Janssen YW; Walsh ES; Vacek P; Mossman BT
Toxicol Appl Pharmacol; 1998 Jul; 151(1):88-97. PubMed ID: 9705890
[TBL] [Abstract][Full Text] [Related]
3. Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, fra-1, and S-phase alterations are mediated via oxidative stress.
Shukla A; Timblin CR; Hubbard AK; Bravman J; Mossman BT
Cancer Res; 2001 Mar; 61(5):1791-5. PubMed ID: 11280724
[TBL] [Abstract][Full Text] [Related]
4. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
6. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
Zanella CL; Posada J; Tritton TR; Mossman BT
Cancer Res; 1996 Dec; 56(23):5334-8. PubMed ID: 8968079
[TBL] [Abstract][Full Text] [Related]
7. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
[TBL] [Abstract][Full Text] [Related]
9. Age-related differences in MAP kinase activity in VSMC in response to glucose or TNF-alpha.
Li M; Mossman BT; Kolpa E; Timblin CR; Shukla A; Taatjes DJ; Fukagawa NK
J Cell Physiol; 2003 Dec; 197(3):418-25. PubMed ID: 14566971
[TBL] [Abstract][Full Text] [Related]
10. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
11. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
Eriksson M; Arminen L; Karjalainen-Lindsberg ML; Leppä S
Exp Cell Res; 2005 Mar; 304(1):175-86. PubMed ID: 15707584
[TBL] [Abstract][Full Text] [Related]
12. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma.
Ramos-Nino ME; Scapoli L; Martinelli M; Land S; Mossman BT
Cancer Res; 2003 Jul; 63(13):3539-45. PubMed ID: 12839939
[TBL] [Abstract][Full Text] [Related]
14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
15. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
16. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
Hurd TW; Culbert AA; Webster KJ; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835
[TBL] [Abstract][Full Text] [Related]
17. The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity.
Shukla A; Flanders T; Lounsbury KM; Mossman BT
Cancer Res; 2004 Nov; 64(21):7780-6. PubMed ID: 15520183
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
Frigo DE; Tang Y; Beckman BS; Scandurro AB; Alam J; Burow ME; McLachlan JA
Carcinogenesis; 2004 Feb; 25(2):249-61. PubMed ID: 14604893
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
20. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
